Patents by Inventor An-Sofie SCHELPE

An-Sofie SCHELPE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Haemorrhagic disorder due to ventricular assist device
    Patent number: 11427649
    Abstract: The present invention relates to methods of treatment by human ADAMTS13 inhibition in circulatory assist device induced haemorrhagic complication such as a bleeding disorder, in particular, bleeding after left ventricular assist device (LVAD) implantation. The present invention further relates to specific monoclonal antibodies inhibiting ADAMTS13 function.
    Type: Grant
    Filed: October 1, 2020
    Date of Patent: August 30, 2022
    Assignee: KATHOLIEKE UNIVERSITEIT LEUVEN
    Inventors: Karen Vanhoorelbeke, Shannen Deconinck, Hendrik Feys, An-Sofie Schelpe
  • Humanised ADAMTS13 binding antibodies
    Patent number: 11339226
    Abstract: The present invention further relates to specific humanised monoclonal antibodies inhibiting ADAMTS13 function. The present invention relates to methods of treatment by human ADAMTS13 inhibition in circulatory assist device induced haemorrhagic complication such as a bleeding disorder, in particular, bleeding after left ventricular assist device (LVAD) implantation.
    Type: Grant
    Filed: June 13, 2018
    Date of Patent: May 24, 2022
    Assignee: Katholieke Universiteit Leuven
    Inventors: Karen Vanhoorelbeke, Shannen F. Deconinck, An-Sofie Schelpe
  • HAEMORRHAGIC DISORDER DUE TO VENTRICULAR ASSIST DEVICE
    Publication number: 20210017292
    Abstract: The present invention relates to methods of treatment by human ADAMTS13 inhibition in circulatory assist device induced haemorrhagic complication such as a bleeding disorder, in particular, bleeding after left ventricular assist device (LVAD) implantation. The present invention further relates to specific monoclonal antibodies inhibiting ADAMTS13 function.
    Type: Application
    Filed: October 1, 2020
    Publication date: January 21, 2021
    Inventors: Karen VANHOORELBEKE, Shannen DECONINCK, Hendrik FEYS, An-Sofie SCHELPE
  • Haemorrhagic disorder due to ventricular assist device
    Patent number: 10829562
    Abstract: The present invention relates to methods of treatment by human ADAMTS13 inhibition in circulatory assist device induced haemorrhagic complication such as a bleeding disorder, in particular, bleeding after left ventricular assist device implantation. The present invention further relates to specific monoclonal antibodies inhibiting ADAMTS13 function.
    Type: Grant
    Filed: December 8, 2016
    Date of Patent: November 10, 2020
    Assignee: KATHOLIEKE UNIVERSITEIT LEUVEN
    Inventors: Karen Vanhoorelbeke, Shannen Deconinck, Hendrik Feys, An-Sofie Schelpe
  • HUMANISED ADAMTS13 BINDING ANTIBODIES
    Publication number: 20200308303
    Abstract: The present invention further relates to specific humanised monoclonal antibodies inhibiting ADAMTS13 function. The present invention relates to methods of treatment by human ADAMTS13 inhibition in circulatory assist device induced haemorrhagic complication such as a bleeding disorder, in particular, bleeding after left ventricular assist device (LVAD) implantation.
    Type: Application
    Filed: June 13, 2018
    Publication date: October 1, 2020
    Inventors: Karen Vanhoorelbeke, Shannen F. Deconinck, An-Sofie Schelpe
  • HAEMORRHAGIC DISORDER DUE TO VENTRICULAR ASSIST DEVICE
    Publication number: 20180362665
    Abstract: The present invention relates to methods of treatment by human ADAMTS13 inhibition in circulatory assist device induced haemorrhagic complication such as a bleeding disorder, in particular, bleeding after left ventricular assist device implantation. The present invention further relates to specific monoclonal antibodies inhibiting ADAMTS13 function.
    Type: Application
    Filed: December 8, 2016
    Publication date: December 20, 2018
    Inventors: Karen VANHOORELBEKE, Shannen DECONINCK, Hendrik FEYS, An-Sofie SCHELPE